Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. announced a change in the name of its H share registrar in Hong Kong from ‘Link Market Services (Hong Kong) Pty Limited’ to ‘MUFG Corporate Markets Pty Limited,’ effective January 20, 2025. This change reflects the company’s ongoing efforts to optimize its administrative functions, though the contact details for the registrar remain unchanged, indicating minimal disruption for stakeholders.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China. The company operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: -3.68%
Average Trading Volume: 10,643
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.9B
For a thorough assessment of 2607 stock, go to TipRanks’ Stock Analysis page.
